Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|March 30, 2001
Rvb1p and Rvb2p are essential components of a chromatin remodeling complex that regulates transcription of over 5% of yeast genesZ O Jónsson, S K Dhar, G J Narlikar, et al.Endocrinology|March 1, 1994
Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and functionJ S Dallas, R K Desai, S J Cunningham, et al.Biomedical Peptides, Proteins & Nucleic Acids : Structure, Synthesis & Biological Activity|January 1, 1995
The intracellular assembly of antigenic-peptide-class II complexesS K Pierce, J M Green, A E Faassen, et al.Prostate Cancer and Prostatic Diseases|December 25, 2013
Successful whole-exome sequencing from a prostate cancer bone metastasis biopsyE M Van Allen, A Foye, N Wagle, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1993
Immunization of mice with Yersinia enterocolitica leads to the induction of antithyrotropin receptor antibodiesG Luo, J L Fan, G S Seetharamaiah, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Measuring the incremental cost of clinical cancer researchD P Goldman, M L Schoenbaum, A L Potosky, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2020
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working GroupF Mosele, J Remon, J Mateo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2020
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancerA G Waks, O Cohen, B Kochupurakkal, et al.Pageof 2